ReactWise enhances drug manufacturing efficiency with AI

ReactWise, a startup from Cambridge, U.K., is using AI to enhance drug manufacturing efficiency. The company claims its technology can speed up the process of optimizing chemical production by 30 times compared to traditional methods. Founded in July 2024, ReactWise has begun pilot trials with 12 pharmaceutical companies, including major players in the industry. The startup aims to reduce the time needed for drug process development, which typically takes one to two years. ReactWise has raised $3.4 million in pre-seed funding, including support from Y Combinator and Innovate U.K. The company focuses on creating high-quality data sets for chemical reactions, which it believes gives it a competitive advantage in the market.